A Covid-19 vaccine for children

---

Purpose: 

The primary purpose of the KidCOVE Study is to test the safety and effectiveness of the study vaccine, called mRNA-1273, that may protect children between the ages of 6 months to < 12 years from getting sick if they come into contact with SARS-CoV-2, which causes COVID-19.  

What to Expect: 

Participation in the KidCOVE Study lasts approximately 14 months and includes phone calls, telemedicine visits, and up to seven visits to the study site.

• Your child will be given two injections in the upper arm – about 28 days apart. Your child has a chance of receiving either the mRNA-1273 study vaccine or the placebo. By using a placebo, medical researchers are able to understand if the study vaccine is effective in preventing COVID-19.
• You and your child will be asked to return to the study site up to six times depending on their enrollment assignment.
• You and your child will have two telemedicine visits with the study doctor after each injection, and then monthly after that to monitor for COVID-19 symptoms. During these phone calls, the study doctor and medical staff will check how your child is feeling and ask for updates on their health.
• You will be asked to use an eDiary app on your smartphone or a provided smartphone to report any COVID-19 symptoms your child experiences.
• Your child will be closely monitored by the study team if any symptoms of COVID-19 are reported at any time throughout their participation.

The study doctor and medical staff will talk to you and your child about additional medical support that your child will receive if he/she experiences COVID-19 symptoms at any time while in this clinical trial. Insurance is not needed to join this clinical trial, and compensation for your family’s time will be available.

Eligibility Criteria: 

Participant must: 

• Be between 6 months to < 12 years old
• Be in good health

Participant must not: 

• Have received an investigational or approved vaccine for COVID-19
• Be currently taking any investigational or approved treatments for COVID-19
• Have tested positive for COVID-19 or been in contact with anyone diagnosed with COVID-19 within 2 weeks prior to vaccine administration
• Have participated in another COVID-19 trial in the past month

Length / Duration:  

Participation in the KidCOVE Study lasts approximately 14 months and includes phone calls, telemedicine visits, and up to seven visits to the study site.

Location:  

13229 Hillsdale Lane, Kissimmee, Florida 34741, United States

Who should you contact: 

Recruitment Department: (407) 350-3979